Bingjun Bai

Dr. Bingjun Bai

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2024 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
LWLiyi Wu
Liyi Wu
LSLina Shan
Lina Shan
DXDengyong Xu
Dengyong Xu
DLDengfeng Lin
Dengfeng Lin
BBBingjun Bai
Bingjun Bai

10 September 2018 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
LSLina Shan
Lina Shan
YLYiming Lv
Yiming Lv
BBBingjun Bai
Bingjun Bai
XHXuefeng Huang
Xuefeng Huang
HZHongbo Zhu
Hongbo Zhu

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
DXDengyong Xu
Dengyong Xu
YXYuzi Xu
Yuzi Xu
YLYiming Lv
Yiming Lv
FWFei Wu
Fei Wu
YLYunlong Liu
Yunlong Liu
BBBingjun Bai
Bingjun Bai
Clear cell renal cell carcinoma (ccRCC) is a major histological subtype of renal cell carcinoma and can be clinically divided into four stages according to the TNM criteria. Identifying clinical stage‐related genes is beneficial for improving the early diagnosis and prognosis of ccRCC. By using bioinformatics analysis, we aim to identify clinical stage‐relevant genes that are significantly associated with the development of ccRCC. First, we analyzed the gene expression microarray data sets: GSE53757 and GSE73731. We divided these data into five groups by staging information—normal tissue and ccRCC stages I, II, III, and IV—and eventually identified 500 differentially expressed genes (DEGs). To obtain precise stage‐relevant genes, we subsequently applied weighted gene coexpression network analysis (WGCNA) to the GSE73731 dataset and KIRC data from The Cancer Genome Atlas (TCGA). Two modules from each dataset were identified to be related to the tumor TNM stage. Several genes with high inner connection inside the modules were considered hub genes. The intersection results between hub genes of key modules and 500 DEGs revealed UBE2C, BUB1B, RRM2, and TPX2 as highly associated with the stage of ccRCC. In addition, the candidate genes were validated at both the RNA expression level and the protein level. Survival analysis also showed that 4 genes were significantly correlated with overall survival. In conclusion, our study affords a deeper understanding of the molecular mechanisms associated with the development of ccRCC and provides potential biomarkers for early diagnosis and individualized treatment for patients at different stages of ccRCC.

28 January 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
LSLina Shan
Lina Shan
DXDengyong Xu
Dengyong Xu
JCJie Chen
Jie Chen
WLWenjia Liu
Wenjia Liu
JLJi Lin
Ji Lin
BBBingjun Bai
Bingjun Bai
Background: Early detection of colorectal cancer (CRC) is crucial for improving patient outcomes. Cell-free DNA (cfDNA) analysis has emerged as a promising non-invasive approach for cancer detection. This study aims to develop a machine learning algorithm leveraging cfDNA fragmentomic features to accurately detect CRC. Methods: 573 individuals from Sir Run Run Shaw Hospital, two community healthcare centers and three additional medical centers, were collected between April 1, 2023, and December 12, 2025. Participants were divided into training, internal validation, and external validation cohorts. A variety of cfDNA fragmentomic features were analyzed and incorporated into machine learning models. The models were evaluated using 10-fold cross-validation and assessed for accuracy, sensitivity, specificity, and AUC values. We also performed differential analysis of key genomic features, such as Alu elements and long terminal repeats (LTRs), between benign and malignant CRC samples. Results: The machine learning algorithm demonstrated robust discriminative performance across all datasets using generalized linear modeling (GLM), achieving AUC values of 0.959 (training set), 0.979 (internal validation cohort), and 0.959 (external validation cohort). Notably, the model exhibited particularly strong classification accuracy for advanced-stage colorectal cancer (CRC). Comparative cfDNA profiling revealed distinct molecular signatures between benign and malignant samples: benign samples were characterized by elevated frequencies of Alu elements and long terminal repeats (LTRs), whereas malignant samples showed distinct end motif profiles, characterized by the significant enrichment of specific 4-mer end motifs. These findings suggest that these molecular features may serve as potential biomarkers for malignancy detection. Conclusion: This study demonstrates that cfDNA fragmentomic profiling, particularly differential patterns of Alu and LTR elements, effectively discriminates benign from malignant colorectal lesions. These findings validate the clinical utility of repetitive element analysis and provide a foundation for developing improved non-invasive CRC diagnostics through machine learning approaches incorporating genomic features.